Journal article icon

Journal article

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles

Abstract:
Malaria is a highly prevalent parasitic disease in regions with tropical and subtropical climates worldwide. Among the species of Plasmodium causing human malaria, P. vivax is the second most prevalent and the most geographically widespread species. A major target of a pre-erythrocytic vaccine is the P. vivax circumsporozoite protein (PvCSP). In previous studies, we fused two recombinant proteins representing three allelic variants of PvCSP (VK210, VK247 and P. vivax-like) to the mumps virus nucleocapsid protein to enhance immune responses against PvCSP. The objective of the present study was to evaluate the protective efficacy of these recombinants in mice challenged with transgenic P. berghei parasites expressing PvCSP allelic variants. Formulations containing Poly (I:C) or Montanide ISA720 as adjuvants elicited high and long-lasting IgG antibody titers specific to each PvCSP allelic variant. Immunized mice were challenged with two existing chimeric P. berghei parasite lines expressing PvCSP-VK210 and PvCSP-VK247. We also developed a novel chimeric line expressing the third allelic variant, PvCSP-P. vivax-like, as a new murine immunization-challenge model. Our formulations conferred partial protection (significant delay in the time to reach 1% parasitemia) against challenge with the three chimeric parasites. Our results provide insights into the development of a vaccine targeting multiple strains of P. vivax.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1038/s41598-021-96986-1

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-8251-1346
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-9259-7339
More by this author
Role:
Author
ORCID:
0000-0003-4402-9131
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7932-2341
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-2419-4415


More from this funder
Funder identifier:
10.13039/501100001807
Grant:
2014/18102-7


Publisher:
Nature Research
Journal:
Scientific Reports More from this journal
Volume:
11
Issue:
1
Pages:
17928-17928
Article number:
17928
Publication date:
2021-09-09
DOI:
EISSN:
2045-2322
ISSN:
2045-2322


Language:
English
Keywords:
Pubs id:
1195832
Local pid:
pubs:1195832
Source identifiers:
W3198280972
Deposit date:
2026-03-26
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP